Roux-en-Y Gastric Bypass Surgery Induces Early Plasma Metabolomic and Lipidomic Alterations in Humans Associated with Diabetes Remission.
Roux-en-Y gastric bypass (RYGB) is an effective method to attain sustained weight loss and diabetes remission. We aimed to elucidate early changes in the plasma metabolome and lipidome after RYGB. Plasma samples from 16 insulin-resistant morbidly obese subjects, of whom 14 had diabetes, were subject...
Main Authors: | Tulika Arora, Vidya Velagapudi, Dimitri J Pournaras, Richard Welbourn, Carel W le Roux, Matej Orešič, Fredrik Bäckhed |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4422729?pdf=render |
Similar Items
-
Metabolic syndrome remission after Roux-en-Y gastric bypass or sleeve gastrectomy
by: Nassour I, et al.
Published: (2017-09-01) -
Type 2 Diabetes Mellitus remission eighteen months after Roux-en-Y gastric bypass.
by: MARCELO GOMES GIRUNDI -
Roux-en-Y gastric bypass
by: Irineu Rasera Junior
Published: (2006-03-01) -
Systems Signatures Reveal Unique Remission-path of Type 2 Diabetes Following Roux-en-Y Gastric Bypass Surgery
by: Qing-Run Li, et al.
Published: (2018-02-01) -
Laparoscopic Roux-en-Y gastric bypass with banding
by: Daniel Lerario, et al.
Published: (2006-03-01)